OnabotulinumtoxinA Significantly Decreases Urinary Incontinence and Provides Treatment Benefit in Patients with Idiopathic Overactive Bladder

Abstract Category

Pharmacology: Clinical

Links
	Abstract 550
	Non Discussion Poster Scientific Non Discussion Poster Session 31
	1. Royal Hallamshire Hospital, 2. Allergan LLC
Abstract PDF Edit Abstract Abstract Centre